SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-039919
Filing Date
2023-02-15
Accepted
2023-02-15 11:18:16
Documents
14
Period of Report
2023-02-14
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d462809d8k.htm   iXBRL 8-K 29359
2 EX-99.1 d462809dex991.htm EX-99.1 9204
6 GRAPHIC g462809dsp4.jpg GRAPHIC 5263
  Complete submission text file 0001193125-23-039919.txt   173226

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acor-20230214.xsd EX-101.SCH 2847
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20230214_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20230214_pre.xml EX-101.PRE 11259
8 EXTRACTED XBRL INSTANCE DOCUMENT d462809d8k_htm.xml XML 3402
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 23634386
SIC: 2836 Biological Products, (No Diagnostic Substances)